11-Nov-2021 - Johann Wolfgang Goethe-Universität Frankfurt (Main)

By capsule through the bloodstream

How intestinal bacteria communicate with the body

Bacteria in the intestine pack a wide spectrum of their biomolecules into small capsules. These are transported via the bloodstream to various organs in the body and even absorbed and processed by nerve cells in the brain. This has now been shown for the first time by a team of researchers from Goethe University, FAU (University of Erlangen-Nuremberg) and the University of California in San Francisco. The newly established research method will help to better understand the influence of intestinal bacteria on diseases and could support the development of innovative forms of drug or vaccine delivery.

In the human body, bacteria are in the majority: According to estimates, there are 1.3 bacterial cells for each human cell. Our bacteria are correspondingly superior to us in their genetic diversity. All intestinal bacteria together – the intestine’s microbiome – have 150 times as many genes as humans. The intestinal bacteria’s metabolic products have a variety of effects on our body: For example, they train our immune cells and contribute to their maturation, they control metabolic processes in the body and how often intestinal mucosa cells renew themselves. It is highly probable that changes in the microbiome’s composition contribute to the development and course of diseases, e.g. neurological disorders or cancer.

The bacterial metabolites act on the cells of the intestinal mucosa via direct contact. However, how such bacterial substances travel to peripheral organs, such as the liver, kidney or brain, had not yet been explained. It was assumed that small capsules (membrane vesicles), released by bacteria into their environment during normal growth or as a reaction to stress and filled with bacterial lipids, proteins or also hereditary RNA molecules, were the means of transport.

An international research team led by Dr Stefan Momma from the Neuroscience Centre of Goethe University, Professor Claudia Günther from FAU (University of Erlangen-Nuremberg) and Professor Robert Raffai from the University of California has now investigated in mice how bacteria distribute their metabolic products in such vesicles. For this purpose, the researchers colonized the intestines of mice with E. coli bacteria, which produced a specific type of gene scissors (Cre) and released these into their environment via vesicles. The mice cells contained a gene for a red fluorescent protein, which could be activated by the Cre gene scissors (Cre/LoxP system).

The result: In the subsequent examination of the mouse tissue, the bacterial vesicles had been absorbed by individual cells in the intestine, liver, spleen, heart and kidneys as well as by immune cells. Consequently, functional Cre contained in the vesicles could enter the cells and lead to the expression of the red marker protein. Even individual nerve cells in the brain glowed red. Stefan Momma: “Particularly impressive is the fact that the bacteria’s vesicles can also overcome the blood-brain barrier and in this way enter the brain – which is otherwise more or less hermetically sealed. And that the bioactive bacterial substances were absorbed by stem cells in the intestinal mucosa shows us that intestinal bacteria can possibly even permanently change its properties.”

The fluorescence images indicate, says Momma, that the vesicles were probably distributed throughout the body via the bloodstream. “The further study of these communication pathways from the bacterial kingdom to individual mammalian cells will not only improve our understanding of conditions such as autoimmune diseases or cancer, in which the microbiome quite obviously plays a significant role. Such vesicles are also extremely interesting as a new method to deliver drugs or develop vaccines, or as biomarkers that point to a pathological change in the microbiome.”

Facts, background information, dossiers

  • bacteria
  • microbiomes
  • vesicles

More about Uni Frankfurt am Main

  • News

    New substance classes for nanomaterials

    Chemists at Goethe University Frankfurt have developed two new classes of materials in the field of nanomaterials and investigated them together with their cooperation partners at the University of Bonn: for the first time, they have succeeded in producing a nano sphere of silicon atoms and ... more

    SARS-CoV-2: Achilles’ heel of viral RNA

    Certain regions of the SARS-CoV-2 genome might be a suitable target for future drugs. This is what researchers at Goethe University, together with their collaborators in the international COVID-19-NMR consortium, have now discovered. With the help of dedicated substance libraries, they have ... more

    Pharmaceutical research: when active substance and target protein “embrace” each other

    Scientists at Goethe University Frankfurt, together with colleagues from Darmstadt, Heidelberg, Oxford and Dundee (UK), have investigated how the fit of potent inhibitors to their binding sites can be optimised so that they engage longer with their target proteins. Long target residency has ... more

  • q&more articles

    From feast to famine and back – no problem for bacteria

    Bacteria are true survivors. In the course of evolution, they have developed numerous strategies to adapt to rapidly changing, uncertain environmental conditions. Their metabolism is much more sophisticated than that of human beings. Within minutes they can regulate their gene expression an ... more

    Why biosimilars and not biogenerics?

    Medicines produced using genetic techniques have existed since 2006, called “similar biological medicinal products” or “biosimilars”. Until a year ago, this was a fairly low-profile group, even in expert circles. This has all changed now, however, with the recent licensing of the first bios ... more

    Paradigm shift

    What would medicine be without drugs? But are these drugs being used optimally today? Not at all, as we now know thanks to the findings of molecular medicine. Because for the use of these drugs, it is important to observe two aspects: the disease and the patient. Only slowly is it becom ... more

  • Authors

    Prof. Dr. Jörg Soppa

    Jörg Soppa, born in 1958, studied biochemistry in Tübingen and then went on to do his doctorate at the Max Planck Institute of Biochemistry in Martinsried near Munich. In 1990 he established his own research group there and held courses at the Institute of Genetics and Microbiology of Munic ... more

    Prof. Dr. Heinfried H. Radeke

    Heinfried H. Radeke studied medicine at the Hannover Medical School (MHH) and received his medical license in 1985. His Ph.D. thesis was recognized as the best research dissertation of 1986. After two years as an assistant physician at the Göttingen University Hospital, he began his career ... more

    Prof. Dr. Theo Dingermann

    Theodor Dingermann, born 1948, studied pharmacy in Erlangen ­and received his doctor title in 1980 to become Dr. rer. nat. In 1990 he was offered the C4 professorship at the Institute for Pharmaceutical Biology, University of Frankfurt.  From 2000 to 2004 he was President of the German Phar ... more

More about Friedrich-Alexander-Universität Erlangen-Nürnberg

  • News

    Carbyne – an unusual form of carbon

    Which photophysical properties does carbyne have? This was the subject of research carried out by scientists at FAU, the University of Alberta, Canada, and the Ecole Polytechnique Fédérale de Lausanne in Switzerland, which has led to a greater understanding of the properties of this unusual ... more

    Zips on the nanoscale

    Nanostructures based on carbon are promising materials for nanoelectronics. However, to be suitable, they would often need to be formed on non-metallic surfaces, which has been a challenge – up to now. Researchers at FAU have found a method of forming nanographenes on metal oxide surfaces. ... more

    Cells that destroy the intestine

    More than 4000,000 people in Germany are affected by the chronic inflammatory bowel diseases Morbus Crohn or ulcerative colitis. Patients often suffer from flare-ups, which damage intestinal tissue. Until now, little has been known about what actually causes flare-ups. Working together with ... more

  • q&more articles

    Colorful off-odors in artists’ paints

    Acrylic-based paints are among the most frequently used by artists. Although they can be produced on a water basis and with low levels of volatile substances, they often still possess a strong inherent smell. However, no targeted studies have as yet been conducted to identify odor-active su ... more

    New Trends in Computer-Aided Drug Design

    Computer-Aided Drug design (CADD) is not new. The Journal of Computer-Aided Molecular Design (Springer) was founded in 1987, when computers in the worldwide top 500 were slower than today’s smart phones. This makes the field a quarter of a century old. Generally, scientific disciplines of t ... more

  • Authors

    Prof. Dr. Andrea Büttner

    Andrea Büttner, born in 1971, studied food chemistry at the Ludwig Maximilian University of Munich. Researching on aromas, she received her doctorate and qualification as a professor from the Technical University of Munich. Since 2007, she has built up the Product Performance business unit ... more

    Prof. Dr. Timothy Clark

    Tim Clark was born in 1949 in England and obtained his Ph.D. from the Queen’s University Belfast in 1973. He is Director of the Computer-Chemie-Centrum in Erlangen and the Centre for Molecular Design at the University of Portsmouth, UK. He develops and applies modelling and simulation techn ... more

More about UCSF

  • News

    Regular caffeine consumption does not result in extra heartbeats

    Contrary to current clinical belief, regular caffeine consumption does not lead to extra heartbeats, which, while common, can lead in rare cases to heart- or stroke-related morbidity and mortality, according to UC San Francisco researchers. The study, which measured the chronic consumption ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by: